Cryo-Cell International, Inc. (CCEL)
NYSEAMERICAN: CCEL · Real-Time Price · USD
3.250
+0.280 (9.43%)
Mar 26, 2026, 4:00 PM EDT - Market closed

Cryo-Cell International Ratios and Metrics

Millions USD. Fiscal year is Dec - Nov.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Nov '25 Nov '24 Nov '23 Nov '22 Nov '21
2635704437106
Market Cap Growth
-49.36%-50.57%58.05%19.35%-64.91%87.08%
Enterprise Value
34.4442.2978.9153.8646.5998.14
Last Close Price
3.254.308.675.354.3712.38
PE Ratio
--14.33173.40-4.6913.2449.52
PS Ratio
0.831.102.191.411.223.67
PB Ratio
--1.86-5.30-4.02-24.3725.30
P/TBV Ratio
-1.41-1.86-5.39-4.04-24.3224.74
P/FCF Ratio
4.996.6019.4321.31-10.3317.38
P/OCF Ratio
4.786.3211.664.974.3313.36
EV/Sales Ratio
1.091.342.471.721.543.40
EV/EBITDA Ratio
23.4728.8118.90-4.948.4419.41
EV/EBIT Ratio
71.4087.6622.67-4.3811.5824.42
EV/FCF Ratio
6.568.0621.8825.88-12.9616.11
Debt / Equity Ratio
-0.59-0.59-0.93-0.95-7.330.15
Debt / EBITDA Ratio
7.887.883.10-1.002.100.56
Debt / FCF Ratio
2.202.203.595.24-3.230.46
Net Debt / Equity Ratio
-0.44-0.44-0.71-0.90-6.49-1.32
Net Debt / EBITDA Ratio
5.635.632.26-0.911.79-1.09
Net Debt / FCF Ratio
1.571.572.624.76-2.75-0.91
Asset Turnover
0.500.500.510.500.480.54
Inventory Turnover
13.8313.8311.1410.369.929.73
Quick Ratio
0.510.510.500.360.400.64
Current Ratio
0.590.590.580.450.490.75
Return on Equity (ROE)
15.27%15.27%-3.32%151.67%208.38%274.30%
Return on Assets (ROA)
0.79%0.79%0.79%-13.90%5.35%6.00%
Return on Invested Capital (ROIC)
0.96%0.96%0.95%-15.96%6.36%8.05%
Return on Capital Employed (ROCE)
1.13%1.13%8.34%-28.69%9.47%11.58%
Earnings Yield
-9.28%-6.98%0.58%-21.31%7.55%2.02%
FCF Yield
20.05%15.15%5.15%4.69%-9.68%5.75%
Dividend Yield
4.62%9.31%2.87%0.00%20.74%0.00%
Payout Ratio
--133.01%502.50%0.00%276.85%0.00%
Buyback Yield / Dilution
1.75%1.75%1.54%1.69%-1.46%-2.72%
Total Shareholder Return
6.37%11.06%4.40%1.69%19.28%-2.72%
Updated Nov 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q